Effects of theophylline, dexamethasone and salbutamol on cytokine gene expression in human peripheral blood CD4+ T-cells

European Respiratory Journal

Volumn 14, Issue 5, 1999, Pages 1106-1112

  Choy, D K L ^b   Ko, F ^b   Li, S T ^b   Ip, L S ^b   Leung, R ^b   Hui, D ^b   Lai, K N ^b   Lai, C K W ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b NONE

Author keywords

Asthma; Corticosteroids; Cytokines; Salbutamol; Theophylline

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; MESSENGER RNA; SALBUTAMOL; THEOPHYLLINE;

ARTICLE; ASTHMA; CONTROLLED STUDY; CYTOKINE RELEASE; GENE EXPRESSION SYSTEM; HELPER CELL; HUMAN; INFLAMMATION; NORMAL HUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032720872     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.99.14511069     Document Type: Article

References (35)

1. Djukanovic R, Wilson JW, Britten KM, et al. Mucosal inflammation in asthma. Am Rev Respir Dis 1990; 142: 434-457.
2. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323: 1033-1039.
3. Kay AB. T-cells, cytokines and asthma. J R Coll Physicians Lond 1994; 28: 325-331.
4. Meijer RJ, Kerstjens HAM, Postma DS. Comparisons of guidelines and self-management plans in asthma. Eur Respir J 1997; 10: 1163-1172.
5. Okayama H, Fushimi T, Shimura S, Sasaki H, Shirato K. Glucocorticoids suppressed production and gene expression of interleukin-5 by peripheral blood mononuclear cells in atopic patients and normal subjects. J Allergy Clin Immunol 1994; 93: 1006-1012.
6. Bentley AM, Hamid Q, Robinson DS, et al. Prednisolone treatment in asthma: reduction in the numbers of eosinophils, T-cells, Tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa. Am J Respir Crit Care Med 1996; 153: 551-556.
7. Lai CKW, Ho SS, Tang J, Chan CHS, Lai KN. Interleukin-5 (IL-5) messenger RNA expression in peripheral blood CD4+ cells in asthma. J Allergy Clin Immunol 1996; 97: 1320-1328.
8. Lai CKW, Ho SS, Chan CHS, Leung R, Lai KN. Gene expression of interleukin-3 and granulocyte macrophage colony-stimulating factor in circulating CD4+ T-cells in acute severe asthma. Clin and Exp Allergy 1996; 26: 138-146.
9. Ward AJM, McKenniff M, Evans JM, Page CP, Costello JF. Theophylline - an immunomodulatory role in asthma? Am Rev Respir Dis 1993; 147: 518-523.
10. Kidney J, Dominguez M, Taylor PM, Rose M, Chung KF, Barnes PJ. Immunomodulation by theophylline in asthma: demonstration by withdrawal of therapy. Am J Respir Crit Care Med 1995; 151: 1907-1914.
11. Barnes PJ, Pauwels RA. Theophylline in asthma: time for reappraisal? Eur Respir J 1994; 7: 579-591.
12. Kita H, Abu-Ghazeleh RI, Gleich GJ, Abraham RT. Regulation of Ig-induced eosinophil degranulation by adenosine 3′, 5′-cyclic monophosphate. J Immunol 1991; 146: 2712-2718.
13. Louis RE, Radermecker MR. Substance P-induced histamine release from human basophils, skin and lung fragments: effect of nedocromil sodium and theophylline. Int Arch Allergy Appl Immunol 1990; 92: 329-333.
14. Essayan DM, Huang S-K, Undem BJ, Kagey-Sobotka A, Lichtenstein LM. Modulation of antigen- and mitogen-induced proliferative responses of peripheral blood mononuclear cells by non-selective and isozyme selective cyclic nucleotide phosphodiesterase inhibitors. J Immunol 1994; 153: 3408-3416.
15. Djukanovic R, Finnerty JP, Lee C, Wilson S, Madden J, Holgate ST. The effects of theophylline on mucosal inflammation in asthmatic airways: biopsy results. Eur Respir J 1995; 8: 831-833.
16. Lai KN, Leung JCK, Li PKT, Larche M, Ritter MA. The effects of blockade of interleukin 2 receptors and interleukin 4 receptors on cytokine production. APMIS 1991; 99: 434-442.
17. Lai KN, Leung JCK, Li PKT, Lui SF. Cytokine production by peripheral blood mononuclear cells in IgA nephropathy. Clin Exp Immunol 1991; 85: 240-245.
18. Brenner CA, Tam AW, Nelson PA, et al. Message amplification phenotyping (MAPPing): a technique to simultaneously measure multiple mRNAs from small numbers of cells. BioTechniques 1989; 7: 1096-1103.
19. Lai KN, Leung JCK, Lai KB, Lai CKW. Effect of Anti-DNA autoantibodies on the gene expression of interleukin 8, transforming growth factor-b, and nitric oxide synthase in cultured endothelial cells. Scand J Rheumatol 1997; 26: 461-467.
20. Weller PF. Cytokine regulation of eosinophil function. Clin Immunol Immunopathol 1992; 62: S55-S59.
21. Del Prete GF, Maggi E, Parronchi P, Chretien I, Tiri A, Macchia D, et al. IL-4 is an essential co-factor for the IgE synthesis induced in vitro by human T-cell clones and their supematants. J Immunol 1988; 140: 4193-4198.
22. Bruseelle GG, Kips JC, Tavernier JH, et al. Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin Exp Allergy 1994; 24: 73-80.
23. Pauwels RA, Brusselle GG, Tournoy KG, Lambrecht BN, Kips JC. Cytokines and their receptors as therapeutic targets in asthma. Clin Exp Allergy 1998; 28: S1-S5.
24. Robinson DS, Ying S, Bentley AM, et al. Relationships among numbers of bronchoalveolar ravage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma. J Allergy Clin Immunol 1993; 92: 397-403.
25. Weinburger M. The pharmacology and therapeutic use of theophylline. JAllergy Clin Immunol 1984; 73: 525-540.
26. Duggan DE, Yeh KC, Matalia MS, Ditzler CA, McMahon FG. Bioavailability of oral dexamethasone. Clin Pharmacol Ther 1975; 18: 205-209.
27. Jaffar ZH, Sullivan P, Page C, Costello J. Low-dose theophylline modulates T-lymphocytes in allergen-challenged asthmatics. Eur Respir J 1996; 9: 456-462.
28. Broide DH, Paine MM, Firestein GF. Eosinophils express interleukin 5 and granulocyte colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. J Clin Invest 1992; 90: 1414-1424.
29. Okayama Y, Semper A, Holgate ST, Church MK. Multiple cytokine mRNA expression in human mast cells stimulated via Fc epsilon RI. Int Arch Allergy Immunol 1995; 107: 158-159.
30. Nassif EG, Weinberger M, Thompson R, Huntley W. The value of maintenance theophylline in steroid-dependent asthma. N Engl J Med 1981; 304: 71.
31. Brenner M, Berkowitz R, Marshall N, Strunk RC. Need for theophylline in severe steroid-requiring asthmatics. Clin Allergy 1988; 18: 143.
32. Evans DJ, Taylor DA, Zetterstrom O, Chung FK, O'Connor BJ, Barnes PJ. A comparison of low-doser inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N Engl J Med 1997; 337: 1412.
33. Sears MR, Taylor DR, Print CG, et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990; 336: 1391-1396.
34. Lai CKW, Twentyman OP, Holgate ST. The effect of an increase in inhaled allergen dose after rimiterol hydrobromide on the occurrence and magnitude of the late asthmatic response and the associated change in non-specific bronchial responsiveness. Am Rev Respir Dis 1989; 140: 917-923.
35. O'Connor BJ, Aikman S, Barnes PJ. Tolerance to the non-bronchodilating effects of inhaled beta-2 agonists in asthma. N Eng J Med 1992; 327: 1204-1208.